Advertisement

Journal of Urban Health

, Volume 81, Issue 4, pp 661–670 | Cite as

A multistate trial of pharmacy syringe purchase

  • Wilson M. ComptonEmail author
  • Joe C. Horton
  • Linda B. Cottler
  • Robert Booth
  • Carl G. Leukefeld
  • Merrill Singer
  • Rence Cunningham-Williams
  • Wendy Reich
  • Karen Fortuin Corsi
  • Michele Staton
  • Joseph L. Fink
  • Thomas J. Stopka
  • Edward L. Spitznagel
Article

Abstract

Pharmacies are a potential site for access to sterile syringes as a means for preventing human immunodeficiency virus (HIV), but the type and extent of their utility is uncertain. To examine pharmacy syringe purchase, we conducted a standardized, multistate study in urban and rural areas of four states in which attempts to purchase syringes were documented. Of 1,600 overall purchase attempts, 35% were refused. Colorado (25%) and Connecticut (28%) had significantly lower rates of refusal than Kentucky (41%) and Missouri (47%). Furthermore, urban settings had higher rates of refusal (40%) than rural settings (31%, P<.01). Race and gender did not have a consistent impact on rates of refusal. Despite potential advantages of pharmacies as sites for access to sterile syringes, pharmacy purchase of syringes faces significant obstacles in terms of the practices in different jurisdictions.

Keywords

HIV/AIDS prevention Injection drug use Pharmacies Syringe purchase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Richard AJ, Mosier V, Atkinson JS. New syringe acquisition and multi-person use of syringes among illegal drug users. J Public Health Policy. 2002;23:324–343.PubMedGoogle Scholar
  2. 2.
    Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001;91:791–793.PubMedGoogle Scholar
  3. 3.
    Burris S, ed. Deregulation of Hypodermic Needles and Syringes as a Public Health Measure: a Report on Emerging Policy and Law in the United States. Washington, DC: American Bar Association; 2001.Google Scholar
  4. 4.
    Compton WM, Cottler LB, Decker SH, Mager D, Stringfellow R. Legal needle buying in St. Louis. Am J Public Health. 1992;82:595–596.PubMedCrossRefGoogle Scholar
  5. 5.
    National Alliance of State and Territorial AIDS Directors. HIV prevention and access to sterile syringes. Joint letter issued by the American Medical Association, American Pharmaceutical Association, Association of State and Territorial Health Officials, National Association of Boards of Pharmacy, National Alliance of State and Territorial AIDS Directors. October 1999. Available at: www.cdc.gov/idu/pubs/hiv_prev_acc.htm. Accessed September 24, 2003.Google Scholar
  6. 6.
    Lundberg GD. New winds blowing for American Drug Policies [editorial]. JAMA. 1997;278:946–947.CrossRefPubMedGoogle Scholar
  7. 7.
    Lurie P, Reingold AL, Browser B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. Prepared for the Centers for Disease Control and Prevention; Berkeley, CA; 1993.Google Scholar
  8. 8.
    Burris S, Welsh J, Ng M, Li M, Ditzler A. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. J Am Pharm Assoc. 2002; 42(6 suppl 2):S94–S98.Google Scholar
  9. 9.
    Klein SJ, Harris-Valente K, Candelas AR, et al. What do pharmacists think about New York State’s new nonprescription syringe sale program? Results of a survey. J Urban Health. 2001;78:679–689.PubMedGoogle Scholar
  10. 10.
    Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc. 2002;42(6 suppl 2):S83–S87.Google Scholar
  11. 11.
    Shotsky WJ, Cooper JG, Klein SJ. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program. Body Positive. 2003;16:15–17.PubMedGoogle Scholar
  12. 12.
    Kassler W, Ayotte D. Deregulation of syringe sale and possession in New Hampshire, 1991–2000. J Am Pharm Assoc. 2002;42(suppl 2):S21–S22.Google Scholar
  13. 13.
    Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. Impact of pharmacybased syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J AIDS. 2001;27:183–192.Google Scholar
  14. 14.
    Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998;113(suppl 1):81–89.PubMedGoogle Scholar
  15. 15.
    Burris S, Vernick JS, Ditzler A, Strathdee S. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S13–S18.Google Scholar
  16. 16.
    Latkin CA, Forman VL. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, USA. J AIDS. 2001;27: 398–404.Google Scholar
  17. 17.
    Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc. 2002;42(6 suppl 2):S77–S82.Google Scholar
  18. 18.
    Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc. 2002;42(suppl 2):S68–S72.Google Scholar
  19. 19.
    Case P, Meredith G, Garcia D, et al. Needle exchange: from civil disobedience to public policy. Multicult Inquiries Res AIDS. 1990;4(4):1–3.Google Scholar
  20. 20.
    Stata Inc.. Stata Documentation Set. College Station, TX: Stata Press; 2001.Google Scholar
  21. 21.
    Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc. 2002;42(suppl 2):S52–S57.Google Scholar
  22. 22.
    Community Epidemiology Work Group. Epidemiological Trends in Drug Abuse—Advance Report Washington, DC: National Institute on Drug Abuse, 2003. NIH Publication 03-5363.Google Scholar
  23. 23.
    Stopka TJ, Singer M, Teng W, Horton J, Compton WM. Pharmacy access to over-the-counter (OTC) syringes in Connecticut: implications for HIV and hepatitis prevention among injection drug users. AIDS Public Policy J. In press.Google Scholar
  24. 24.
    Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S62–S67.Google Scholar
  25. 25.
    Jones TS, Coffin PO. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc. 2002;42(6 suppl 2):S6–S9.Google Scholar
  26. 26.
    Lewis BA, Koester SK, Bush TW. Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc. 2002;42(6 suppl 2): S46–S51.Google Scholar
  27. 27.
    Taussig J, Junge B, Burris S, Jones TS, Sterk CE. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002;42(6 suppl 2):S40–S45.Google Scholar
  28. 28.
    Blumenthal WJ, Springer KW, Jones TS, Sterk CE. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002: 42(6 suppl 2):S34–S39.Google Scholar
  29. 29.
    Rich JD, Whitlock TL, Towe CW, et al. Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island. Subst Use Misuse. 2001;36(5):535–550.CrossRefPubMedGoogle Scholar
  30. 30.
    Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40–45.CrossRefPubMedGoogle Scholar
  31. 31.
    Harbke CR, Fisher DG, Cagle HH, Trubatch BN, Fenaughty AM, Johnson ME. Telephone survey of Alaskan pharmacists’ nonprescription needle-selling practices. J Urban Health. 2000;77:113–120.CrossRefPubMedGoogle Scholar
  32. 32.
    Simpson HL. Injection drug users and pharmacists: a call for compassion, cooperation, and care. J Am Pharm Assoc. 2002;42 (6 suppl 2):S10–S12.Google Scholar

Copyright information

© The New York Academy of Medicine 2004

Authors and Affiliations

  • Wilson M. Compton
    • 1
    Email author
  • Joe C. Horton
    • 2
  • Linda B. Cottler
    • 3
  • Robert Booth
    • 4
  • Carl G. Leukefeld
    • 5
  • Merrill Singer
    • 6
  • Rence Cunningham-Williams
    • 2
  • Wendy Reich
    • 2
  • Karen Fortuin Corsi
    • 4
  • Michele Staton
    • 5
  • Joseph L. Fink
    • 5
  • Thomas J. Stopka
    • 7
  • Edward L. Spitznagel
    • 2
  1. 1.National Institute on Drug AbuseBethesda
  2. 2.Entrenar Inc.St. Louis
  3. 3.Washington UniversitySt. Louis
  4. 4.University of KentuckyLexington
  5. 5.University of KentuckyLexington
  6. 6.Hispanic Research CouncilHartford
  7. 7.Office of AIDS, California Department of Health ServicesSacramento

Personalised recommendations